MediciNova, Inc.

Overview

MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs. The company’s development pipeline targets areas such as neurology, respiratory, and liver diseases, with a commitment to advancing its clinical programs.

Therapeutic areas

API / Drug Master Files

MediciNova, Inc. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• KUR-1246 DRUG SUBSTANCEActive2004-10-07

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MediciNova, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.